AME vs INTS
Ametek Inc (AME) versus Intensity Therapeutics, Inc. Common stock (INTS) — a side-by-side from cached financials, not a winner call.
Ametek Inc (AME) is a specialty industrial machinery company listed on US.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Latest reported AME revenue for 2024-12-31 was $6.94B. Net income was $1.38B. Revenue was up 5.2% from 2023-12-31 to 2024-12-31. AME currently screens at market cap $42.11B and trailing P/E 29.9.
INTS does not have a complete income-statement cache yet.
AME currently screens at market cap $42.11B and trailing P/E 29.9. INTS currently screens at market cap $7.7M.
Not investment advice. Open the AME and INTS stock pages for the full models.
Not investment advice.